202 related articles for article (PubMed ID: 17149664)
41. Infectious diseases: statutory notification and surveillance.
Peate I
Br J Nurs; 1999 Jul 22-Aug 11; 8(14):943-7. PubMed ID: 10711018
[TBL] [Abstract][Full Text] [Related]
42. [New infection control regulation should improve prevention. Severe vaccination reactions require notification].
Eiden P
MMW Fortschr Med; 2001 Apr; 143(14):12. PubMed ID: 11340903
[No Abstract] [Full Text] [Related]
43. [Not Available].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Jun; 59(6):818. PubMed ID: 27221548
[No Abstract] [Full Text] [Related]
44. [More and faster notification of infectious disease if notification is carried out by the laboratories instead of the diagnosing physician].
Rietveld A; Schneeberger PM; Wijkmans CJ
Ned Tijdschr Geneeskd; 2005 Feb; 149(6):304-7. PubMed ID: 15730039
[TBL] [Abstract][Full Text] [Related]
45. To notify or not to notify: decision aid for policy makers on whether to make an infectious disease mandatorily notifiable.
Bijkerk P; Fanoy EB; Kardamanidis K; van der Plas SM; Te Wierik MJ; Kretzschmar ME; Haringhuizen GB; van Vliet HJ; van der Sande MA
Euro Surveill; 2015; 20(34):30003. PubMed ID: 26530302
[TBL] [Abstract][Full Text] [Related]
46. A standardized process for developing a national notifiable diseases list in a pacific island setting.
Pavlin BI; Kool JL; Samo MH; Gerstel L;
Asia Pac J Public Health; 2010 Jul; 22(3):279-88. PubMed ID: 19666949
[TBL] [Abstract][Full Text] [Related]
47. [Adaptation of the routine surveillance system for infectious diseases in 2020 in the context of the COVID-19 pandemic].
Diercke M; Claus H; Rexroth U; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2021 Apr; 64(4):388-394. PubMed ID: 33847762
[TBL] [Abstract][Full Text] [Related]
48. [Case definition of the Robert Koch Institute for the new MRSA mandatory notification according to decree in compliance with mandatory notification in section IfSG regarding the epidemiologic status of 26 May 2009. MRSA (methicillin resistant Staphylococcus aureus) in blood culture and cerebrospinal fluid].
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Oct; 52(10):962-3. PubMed ID: 19802618
[No Abstract] [Full Text] [Related]
49. Utilization of case definitions and laboratory reporting in the surveillance of notifiable communicable diseases in the United States.
Sacks JJ
Am J Public Health; 1985 Dec; 75(12):1420-2. PubMed ID: 4061715
[TBL] [Abstract][Full Text] [Related]
50. A critical review of the infectious diseases surveillance system in the Gaza Strip.
Awad R; Al Rahman Omer A; Abu Shahla N
East Mediterr Health J; 2001; 7(1-2):274-9. PubMed ID: 12596978
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of Australia's National Notifiable Disease Surveillance System.
Miller M; Roche P; Spencer J; Deeble M
Commun Dis Intell Q Rep; 2004; 28(3):311-23. PubMed ID: 15574055
[TBL] [Abstract][Full Text] [Related]
52. Active case-finding of communicable diseases in the south of the Islamic Republic of Iran.
Karimi A; Kadivar MR; Fararoee M; Alborzi A
East Mediterr Health J; 2000; 6(2-3):487-93. PubMed ID: 11556041
[TBL] [Abstract][Full Text] [Related]
53. Surveillance on speed: Being aware of infectious diseases in migrants mass accommodations - an easy and flexible toolkit for field application of syndromic surveillance, Germany, 2016 to 2017.
Sarma N; Ullrich A; Wilking H; Ghozzi S; Lindner AK; Weber C; Holzer A; Jansen A; Stark K; Vygen-Bonnet S
Euro Surveill; 2018 Oct; 23(40):. PubMed ID: 30301488
[TBL] [Abstract][Full Text] [Related]
54. [General practitioners and mandatory surveillance of communicable diseases: a descriptive study in Puglia (South Italy)].
Prato R; Napoli C; Barbuti G; Germinario C; Lopalco PL
Ann Ig; 2004; 16(3):449-55. PubMed ID: 15368936
[TBL] [Abstract][Full Text] [Related]
55. National Notifiable Diseases Surveillance System, 1 January to 31 March 2015.
Australian Government Department of Health
Commun Dis Intell Q Rep; 2015 Jun; 39(2):E285-91. PubMed ID: 26234262
[No Abstract] [Full Text] [Related]
56. Australia's notifiable diseases status, 2001: annual report of the National Notifiable Diseases Surveillance System.
Blumer C; Roche P; Spencer J; Lin M; Milton A; Bunn C; Gidding H; Kaldor J; Kirk M; Hall R; Della-Porta T; Leader R; Wright P; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Commun Dis Intell Q Rep; 2003; 27(1):1-78. PubMed ID: 12725505
[TBL] [Abstract][Full Text] [Related]
57. Australia's notifiable disease status, 2009: annual report of the National Notifiable Diseases Surveillance System.
Slaon-Gardner T; Stirzaker S; Knuckey D; Pennington K; Knope K; Fitzsimmons G; Martin N; Siripol S; Richards K; Witheridge J; Wright P; Barry C; Ormond J;
Commun Dis Intell Q Rep; 2011 Jun; 35(2):61-131. PubMed ID: 22010505
[TBL] [Abstract][Full Text] [Related]
58. Australia's notifiable disease status, 2011: annual report of the National Notifiable Diseases Surveillance System.
NNDSS Annual Report Writing Group
Commun Dis Intell Q Rep; 2013 Dec; 37(4):E313-93. PubMed ID: 24882235
[TBL] [Abstract][Full Text] [Related]
59. Sensitivity of the Swedish statutory surveillance system for communicable diseases 1998-2002, assessed by the capture-recapture method.
Jansson A; Arneborn M; Ekdahl K
Epidemiol Infect; 2005 Jun; 133(3):401-7. PubMed ID: 15962546
[TBL] [Abstract][Full Text] [Related]
60. Reliability of case definitions for public health surveillance assessed by Round-Robin test methodology.
Krause G; Brodhun B; Altmann D; Claus H; Benzler J
BMC Public Health; 2006 May; 6():129. PubMed ID: 16686946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
